Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma

Small-molecule inhibitor of apoptosis (IAP) antagonists, called Smac mimetic compounds (SMCs), sensitize tumours to TNF-α-induced killing while simultaneously blocking TNF-α growth-promoting activities. SMCs also regulate several immunomodulatory properties within immune cells. We report that SMCs s...

Full description

Saved in:
Bibliographic Details
Published in:Nat Commun
Main Authors: Beug, Shawn T., Beauregard, Caroline E., Healy, Cristin, Sanda, Tarun, St-Jean, Martine, Chabot, Janelle, Walker, Danielle E., Mohan, Aditya, Earl, Nathalie, Lun, Xueqing, Senger, Donna L., Robbins, Stephen M., Staeheli, Peter, Forsyth, Peter A., Alain, Tommy, LaCasse, Eric C., Korneluk, Robert G.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330852/
https://ncbi.nlm.nih.gov/pubmed/28198370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms14278
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items